Please try another search
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.
Name | Age | Since | Title |
---|---|---|---|
Andrzej Trznadel | - | - | Chairman of Supervisory Board |
Mariusz Czekala | - | - | Member of Supervisory Board |
Tadeusz Wesolowski | - | - | Vice-Chairman of the Supervisory Board |
Konrad Rejdak | - | - | Member of Scientific Advisory Board |
Julia Bar | - | - | Member of Supervisory Board |
Radoslaw Zagozdzon | - | - | Member of Scientific Advisory Board |
Boguslaw Paradowski | - | - | Member of Scientific Advisory Board |
Pawel Wisniewski | - | 2023 | Member of the Supervisory Board |
Jacek Otlewski | - | - | Member of Scientific Advisory Board |
Waldemar Priebe | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review